Search results
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments
Pharmaceutical Technology via Yahoo Finance· 10 hours agoMany significant Phase I-III studies targeting haematological malignancies, such as multiple myeloma...
Cessation to launch Phase IIa monoclonal antibody trial in opioid abuse
Clinical Trials Arena via Yahoo Finance· 2 days agoCessation Therapeutics will be advancing its investigational monoclonal antibody to a Phase IIa...
New immunotherapy shows promise for advanced colorectal cancer in early trial
MedicalNewsToday via AOL· 2 days agoA combination of two monoclonal antibodies was effective in 61% of people with the most common form...
Alzheimer's drug's potentially fatal side effect, ARIA, obscured by 'soothing acronym,' doctors say
LA Times via Yahoo News· 5 days agoGenevieve Lane, who took Leqembi, died of a mysterious side effect called ARIA. Her death, and those...
Beyond BCMA-Directed CAR T-Cell Therapy
MedPage Today· 1 day agoAlthough survival rates for patients with multiple myeloma are improving, with a 5-year rate of about 60%, many patients relapse after treatment. "Patients have seen impressive advances in survival ...
Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia
MedPage Today· 3 days agoAn investigational anti-CD38 monoclonal antibody (CM313) rapidly increased platelets in immune...
Keymed reports positive data of CM313 in immune thrombocytopenia trial
Clinical Trials Arena via Yahoo Finance· 21 hours agoCM313 is a humanised monoclonal antibody intended for targeting CD38. The study has been designed to...
The Swiftly Evolving Story of EGFR-Mutated NSCLC Management
MedPage Today· 18 hours agoFor patients with non-small lung cancer (NSCLC), the ADAURA, FLAURA and MARIPOSA trials bestowed...
Exploring Hidden Gems on SEHK: 3 Stocks Estimated as Undervalued in June 2024
Simply Wall St. via Yahoo Finance· 4 days agoAmidst a backdrop of fluctuating global markets, the Hong Kong stock exchange has shown resilience,...
Gateway - Quartz
Quartz· 4 days agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative drug in history. Since entering the market in 2003, ...
